University of Utah
The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with narcolepsy. All participants will receive the treatment and will complete three assessments. Half of the participants will receive the treatment after the first assessment, and half will receive it after the second assessment. Romantic partners of participants with narcolepsy will also be eligible to enroll in the study. Partners will complete three assessments but will not participate in the treatment.
PARTICIPANTS WITH NARCOLEPSY/NIGHTMARES Inclusion Criteria: * Diagnosis of narcolepsy type 1 or narcolepsy type 2 * Nightmare frequency of ≥1 times per week * Age 18 or older * Able to speak, read, and write in English * Live in the United States * Sleep and psychiatric medications stable for ≥ 1 month and willing to keep medications stable for the duration of the study Exclusion Criteria: * Currently engaged in trauma- or sleep-related psychotherapy * Previous behavioral treatment for nightmares * Medical, psychiatric, or cognitive condition which would interfere with ability to engage in…
The intervention will consist of 7 therapy sessions (once per week for 7 weeks) which will be delivered via videoconference. During the sessions, participants will learn techniques for managing and changing nightmares.
Arctuva estimate
Verify or correct the compensation shown for this listing.